Home  »  Markets   »  Why Hims & Hers Health Inc. (HIMS) Stock Coul...

Why Hims & Hers Health Inc. (HIMS) Stock Could See Much Higher Prices Ahead

Hims & Hers Health Inc. (NYSE: HIMS) is 19.03% higher on its value in year-to-date trading and has touched a low of $2.72 and a high of $7.97 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HIMS stock was last observed hovering at around $7.26 in the last trading session, with the day’s gains setting it 0.37% off its average median price target of $7.00 for the next 12 months. It is also 36.42% off the consensus price target high of $12.00 offered by 9 analysts, but current levels are -52.6% lower than the price target low of $5.00 for the same period.

Currently trading at $7.63, the stock is 13.21% and 16.97% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.44 million and changing 5.10% at the moment leaves the stock 40.29% off its SMA200. HIMS registered 58.30% gain for a year compared to 6-month gain of 30.87%.

5 Undervalued Stocks For 2023

Approximately 544 miles north of Las Vegas lies what's been dubbed "the biggest lithium deposit in the US." One tiny company stands to be the biggest beneficiary because lithium "faces a long-term supply shortage," according to Barron's. This company, however, is sitting on a goldmine opportunity as it plans to produce 30,000 tonnes per annum over the next 3.5 years from this single deposit. Supplying the electric vehicle boom and potentially driving its stock price off the charts. But this is just one of the opportunities we have researched in our free report. The other four companies have just as much potential.

Click here to download your Free Copy…


The stock witnessed a 14.74% loss in the last 1 month and extending the period to 3 months gives it a 78.27%, and is 1.33% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.26% over the week and 5.17% over the month.

Hims & Hers Health Inc. (HIMS) has around 398 employees, a market worth around $1.63B and $444.40M in sales. Profit margin for the company is -19.30%. Distance from 52-week low is 180.51% and -4.27% from its 52-week high. The company has generated returns on investments over the last 12 months (-33.50%).

Hims & Hers Health Inc. (HIMS) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Hims & Hers Health Inc. (HIMS) is a “Overweight”. 9 analysts offering their recommendations for the stock have an average rating of 2.20, where 5 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Hims & Hers Health Inc. is expected to release its quarterly report on 05/15/2023.The EPS is expected to shrink by -375.60% this year.

Hims & Hers Health Inc. (HIMS) Top Institutional Holders

The shares outstanding are 205.23M, and float is at 155.83M with Short Float at 10.37%.

Hims & Hers Health Inc. (HIMS) Insider Activity

A total of 50 insider transactions have happened at Hims & Hers Health Inc. (HIMS) in the last six months, with sales accounting for 24 and purchases happening 26 times. The most recent transaction is an insider sale by Boughton Soleil,the company’sChief Legal Officer. SEC filings show that Boughton Soleil sold 2,000 shares of the company’s common stock on Jan 17 at a price of $7.51 per share for a total of $15020.0. Following the sale, the insider now owns 0.29 million shares.

Hims & Hers Health Inc. disclosed in a document filed with the SEC on Jan 03 that Boughton Soleil (Chief Legal Officer) sold a total of 12,345 shares of the company’s common stock. The trade occurred on Jan 03 and was made at $6.50 per share for $80242.0. Following the transaction, the insider now directly holds 0.29 million shares of the HIMS stock.

Still, SEC filings show that on Dec 19, Boughton Soleil (Chief Legal Officer) disposed off 13,744 shares at an average price of $6.72 for $92360.0. The insider now directly holds 301,434 shares of Hims & Hers Health Inc. (HIMS).

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts